NO992225L - FremgangsmÕte for fremstilling av salter og estere av klavulansyre - Google Patents

FremgangsmÕte for fremstilling av salter og estere av klavulansyre

Info

Publication number
NO992225L
NO992225L NO992225A NO992225A NO992225L NO 992225 L NO992225 L NO 992225L NO 992225 A NO992225 A NO 992225A NO 992225 A NO992225 A NO 992225A NO 992225 L NO992225 L NO 992225L
Authority
NO
Norway
Prior art keywords
esters
preparation
clavulanic acid
salts
pharmaceutically acceptable
Prior art date
Application number
NO992225A
Other languages
English (en)
Other versions
NO992225D0 (no
Inventor
Johannes Booij
Antonius Van Den Heuvel
Original Assignee
Gist Brocades Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Bv filed Critical Gist Brocades Bv
Publication of NO992225L publication Critical patent/NO992225L/no
Publication of NO992225D0 publication Critical patent/NO992225D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

En forbedret fremgangsmåte for fremstillingen av farmasøytisk akseptable alkalimetallsalter eller estere av klavulansyre er blitt tilveiebrakt. Videre er det også blitt tilveiebrakt kaliumklavulanat med et ekstremt lavt amininnhold og farmasøytiske sammensetninger som inneholder det samme.
NO992225A 1996-11-11 1999-05-07 FremgangsmÕte for fremstilling av salter og estere av klavulansyre NO992225D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96203117 1996-11-11
PCT/EP1997/006263 WO1998021212A1 (en) 1996-11-11 1997-11-10 Process for the preparation of salts and esters of clavulanic acid

Publications (2)

Publication Number Publication Date
NO992225L true NO992225L (no) 1999-05-07
NO992225D0 NO992225D0 (no) 1999-05-07

Family

ID=8224563

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992225A NO992225D0 (no) 1996-11-11 1999-05-07 FremgangsmÕte for fremstilling av salter og estere av klavulansyre

Country Status (11)

Country Link
EP (1) EP0937084A1 (no)
JP (1) JP2001503763A (no)
CN (1) CN1238776A (no)
AU (1) AU5551698A (no)
BR (1) BR9713339A (no)
CA (1) CA2271847A1 (no)
NO (1) NO992225D0 (no)
PL (1) PL333247A1 (no)
TR (1) TR199901631T2 (no)
WO (1) WO1998021212A1 (no)
ZA (1) ZA9710141B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400033B (de) 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
SI9500134B (sl) * 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
EP1095046A1 (en) * 1998-07-16 2001-05-02 Dsm N.V. Improved process for the preparation of salts and esters of clavulanic acid
CA2364342C (en) * 1999-04-01 2011-02-01 Dsm N.V. Agglomerates by crystallisation
WO2001087891A1 (en) * 2000-05-13 2001-11-22 Smithkline Beecham P.L.C. Process for the purification of a salt of clavulanic acid
KR20090094261A (ko) * 2006-12-01 2009-09-04 디에스엠 아이피 어셋츠 비.브이. 클라부란산의 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
GB9305565D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Novel compounds and processes
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9426261D0 (en) * 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500134B (sl) * 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) * 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법

Also Published As

Publication number Publication date
EP0937084A1 (en) 1999-08-25
JP2001503763A (ja) 2001-03-21
CA2271847A1 (en) 1998-05-22
BR9713339A (pt) 2000-05-09
PL333247A1 (en) 1999-11-22
WO1998021212A1 (en) 1998-05-22
AU5551698A (en) 1998-06-03
CN1238776A (zh) 1999-12-15
NO992225D0 (no) 1999-05-07
TR199901631T2 (xx) 1999-09-21
ZA9710141B (en) 1998-06-25

Similar Documents

Publication Publication Date Title
AU7035094A (en) New 11-benzaldoxime-estradiene-derivatives, methods for their production and pharmaceuticals containing these substances
HK1010690A1 (en) (3R,4r)-delta6 -tetrahydrocannabinol-7-oic acids
ES8705387A1 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
AU7672294A (en) Compositions and methods for the administration of delta-aminolevulinic acid
IE851918L (en) An indole derivative.
MD1233C2 (ro) Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora
MX9700374A (es) Formulaciones acuosas de risperidona.
AU6546890A (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
AU3475097A (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
AU1266288A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
HK1018590A1 (en) Administration regimen of h+, k+-atpase inhibitors
NO960653L (no) Nytt, farmasöytisk middel for oral administrering omfattende progesteron og en polyetylenglykol sammen med en eksipiens
EP0773022A3 (de) Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure
DK0748387T3 (da) Fremgangsmåde til isolation af clavulansyre og farmaceutisk acceptable salte deraf fra fermenteringsvæsken af Streptomyces sp. P 6621 FERM P 2804
PL305091A1 (en) Novel derivatives of 11-benzaldoxim-17beta-methoxy-17alpha methoxymethyl estradiene, method of obtaining them and therapeutic agents containing such compounds
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
NO992225L (no) FremgangsmÕte for fremstilling av salter og estere av klavulansyre
AU579111B2 (en) Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
EP0329008A3 (de) Cephalosporinderivative und Verfahren zu ihrer Herstellung
AU1891683A (en) Substituted 1-phenyl-isoquinoline anti-arrythmic agents
IE872667L (en) Pharmaceutical compositions
AU8844091A (en) Novel dihydroquinoline derivatives, pharmaceutical compositions and methods of use of dihidroquinoline derivatives as modulators of the arachidonic acid cascade
MY114213A (en) Clavulanic acid salts
JO2040B1 (en) Method for preparing salts and esters (bacilli salts) from clavulic acid
NO920050L (no) Trifluormetyl-1-karba(1-detia)cefemer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application